Forte Biosciences (FBRX) Other Accumulated Expenses (2016 - 2026)
Forte Biosciences' Other Accumulated Expenses came in at $83,000 for Q2 2026, down 1.2% from $84,000 a year earlier but up 1.2% from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
At the end of FY2025, Forte Biosciences' Other Accumulated Expenses was $8,000, down 93.9% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of -30.7% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $132,000 in FY2024, $3,000 in FY2023 (-62.5%), $8,000 in FY2022 (-50.0%) and $16,000 in FY2021 (-68.0%).
- The five-year range for quarterly Other Accumulated Expenses is $3,000 (Q4 2023) to $141,000 (Q1 2022).
- Year-over-year, Other Accumulated Expenses has declined for three consecutive quarters, with growth averaging 74.5% over the last six quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q1 2022 (growth of 984.6%), and the weakest in Q4 2025 (a decline of 93.9%).
- Business Quant data shows FBRX's Other Accumulated Expenses at $82,000 (Q1 2026), $8,000 (Q4 2025) and $30,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83,000.00 |
| Mar 31, 2026 | 82,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 70,000.00 |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 141,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 61,000.00 |
| Jun 30, 2021 | 63,000.00 |
API Access
Forte Biosciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();